These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
3. Defining cardiovascular toxicities of cancer therapies: an International Cardio-Oncology Society (IC-OS) consensus statement. Herrmann J; Lenihan D; Armenian S; Barac A; Blaes A; Cardinale D; Carver J; Dent S; Ky B; Lyon AR; López-Fernández T; Fradley MG; Ganatra S; Curigliano G; Mitchell JD; Minotti G; Lang NN; Liu JE; Neilan TG; Nohria A; O'Quinn R; Pusic I; Porter C; Reynolds KL; Ruddy KJ; Thavendiranathan P; Valent P Eur Heart J; 2022 Jan; 43(4):280-299. PubMed ID: 34904661 [TBL] [Abstract][Full Text] [Related]
4. Diagnosis, Treatment, and Prevention of Cardiovascular Toxicity Related to Anti-Cancer Treatment in Clinical Practice: An Opinion Paper from the Working Group on Cardio-Oncology of the Korean Society of Echocardiography. Kim H; Chung WB; Cho KI; Kim BJ; Seo JS; Park SM; Kim HJ; Lee JH; Kim EK; Youn HJ J Cardiovasc Ultrasound; 2018 Mar; 26(1):1-25. PubMed ID: 29629020 [TBL] [Abstract][Full Text] [Related]
5. Rationale for setting up a cardio-oncology unit: our experience at Mayo Clinic. Barros-Gomes S; Herrmann J; Mulvagh SL; Lerman A; Lin G; Villarraga HR Cardiooncology; 2016 Apr; 2(1):5. PubMed ID: 33530144 [TBL] [Abstract][Full Text] [Related]
6. An international survey of healthcare providers' knowledge of cardiac complications of cancer treatments. Peng J; Rushton M; Johnson C; Brezden-Masley C; Sulpher J; Chiu MG; Graham ID; Dent S Cardiooncology; 2019; 5():12. PubMed ID: 32154018 [TBL] [Abstract][Full Text] [Related]
7. Cardio-Oncology: A Focused Review of Anthracycline-, Human Epidermal Growth Factor Receptor 2 Inhibitor-, and Radiation-Induced Cardiotoxicity and Management. Domercant J; Polin N; Jahangir E Ochsner J; 2016; 16(3):250-6. PubMed ID: 27660573 [TBL] [Abstract][Full Text] [Related]
9. Role of cardiovascular imaging in cancer patients receiving cardiotoxic therapies: a position statement on behalf of the Heart Failure Association (HFA), the European Association of Cardiovascular Imaging (EACVI) and the Cardio-Oncology Council of the European Society of Cardiology (ESC). Čelutkienė J; Pudil R; López-Fernández T; Grapsa J; Nihoyannopoulos P; Bergler-Klein J; Cohen-Solal A; Farmakis D; Tocchetti CG; von Haehling S; Barberis V; Flachskampf FA; Čeponienė I; Haegler-Laube E; Suter T; Lapinskas T; Prasad S; de Boer RA; Wechalekar K; Anker MS; Iakobishvili Z; Bucciarelli-Ducci C; Schulz-Menger J; Cosyns B; Gaemperli O; Belenkov Y; Hulot JS; Galderisi M; Lancellotti P; Bax J; Marwick TH; Chioncel O; Jaarsma T; Mullens W; Piepoli M; Thum T; Heymans S; Mueller C; Moura B; Ruschitzka F; Zamorano JL; Rosano G; Coats AJS; Asteggiano R; Seferovic P; Edvardsen T; Lyon AR Eur J Heart Fail; 2020 Sep; 22(9):1504-1524. PubMed ID: 32621569 [TBL] [Abstract][Full Text] [Related]
10. Practices in management of cancer treatment-related cardiovascular toxicity: A cardio-oncology survey. Jovenaux L; Cautela J; Resseguier N; Pibarot M; Taouqi M; Orabona M; Pinto J; Peyrol M; Barraud J; Laine M; Bonello L; Paganelli F; Barlesi F; Thuny F Int J Cardiol; 2017 Aug; 241():387-392. PubMed ID: 28365180 [TBL] [Abstract][Full Text] [Related]
11. Cardio-Oncology Services: rationale, organization, and implementation. Lancellotti P; Suter TM; López-Fernández T; Galderisi M; Lyon AR; Van der Meer P; Cohen Solal A; Zamorano JL; Jerusalem G; Moonen M; Aboyans V; Bax JJ; Asteggiano R Eur Heart J; 2019 Jun; 40(22):1756-1763. PubMed ID: 30085070 [TBL] [Abstract][Full Text] [Related]
12. "Inherited cardiovascular disease mindset" can identify concealed inherited conditions at cardio-oncology evaluation: An opportunistic screening. Lorca R; Fernández M; Avanzas P; Pascual I; Álvarez-Velasco R; Silva I; Gutiérrez L; Gómez J; Muñiz M; Álvarez C; Esteban E; López-Fernández T Int J Cardiol; 2024 Apr; 401():131825. PubMed ID: 38309590 [TBL] [Abstract][Full Text] [Related]
13. Cardio-Oncology Educational Program: National Survey as the First Step to Start. Kozhukhov S; Dovganych N Front Cardiovasc Med; 2021; 8():697240. PubMed ID: 34409077 [No Abstract] [Full Text] [Related]
14. Cancer Therapy-Related Cardiovascular Complications in Clinical Practice: Current Perspectives. Bohdan M; Kowalczys A; Mickiewicz A; Gruchała M; Lewicka E J Clin Med; 2021 Apr; 10(8):. PubMed ID: 33924543 [TBL] [Abstract][Full Text] [Related]
15. Global pattern of cardiovascular disease management in patients with cancer and impact of COVID-19 on drug selection: IRAQ-IC-OS survey-based study. Farhan HA; Yaseen IF; Alomar M; Lenihan D; Dent S; Lyon AR Front Cardiovasc Med; 2022; 9():979631. PubMed ID: 36211547 [TBL] [Abstract][Full Text] [Related]
16. Emerging cancer therapies and cardiovascular risk. Bottinor W; Parikh A; Jahangir E J Thromb Thrombolysis; 2021 May; 51(4):837-845. PubMed ID: 32886244 [TBL] [Abstract][Full Text] [Related]
17. An Overview of Cardio-Oncology, a New Frontier to Be Explored. Cheng KH; Wu YW; Hou CJ; Hung CM Acta Cardiol Sin; 2021 Sep; 37(5):457-463. PubMed ID: 34584378 [TBL] [Abstract][Full Text] [Related]
18. Cardio-oncology Clinical Assessment and Screening in Patients Undergoing High Toxicity Chemotherapy: A Retrospective Cohort Study. Regino CA; Cardona-Vélez J; Bello Simanca JD; Miranda Arboleda AF; Gamboa Arroyave JG; Jaimes F Cureus; 2022 Dec; 14(12):e32513. PubMed ID: 36654601 [TBL] [Abstract][Full Text] [Related]
19. Role of serum biomarkers in cancer patients receiving cardiotoxic cancer therapies: a position statement from the Cardio-Oncology Study Group of the Heart Failure Association and the Cardio-Oncology Council of the European Society of Cardiology. Pudil R; Mueller C; Čelutkienė J; Henriksen PA; Lenihan D; Dent S; Barac A; Stanway S; Moslehi J; Suter TM; Ky B; Štěrba M; Cardinale D; Cohen-Solal A; Tocchetti CG; Farmakis D; Bergler-Klein J; Anker MS; Von Haehling S; Belenkov Y; Iakobishvili Z; Maack C; Ciardiello F; Ruschitzka F; Coats AJS; Seferovic P; Lainscak M; Piepoli MF; Chioncel O; Bax J; Hulot JS; Skouri H; Hägler-Laube ES; Asteggiano R; Fernandez TL; de Boer RA; Lyon AR Eur J Heart Fail; 2020 Nov; 22(11):1966-1983. PubMed ID: 33006257 [TBL] [Abstract][Full Text] [Related]
20. Cardio-oncology rehabilitation: are we ready? Bisceglia I; Venturini E; Canale ML; Ambrosetti M; Riccio C; Giallauria F; Gallucci G; Abrignani MG; Russo G; Lestuzzi C; Mistrulli R; De Luca G; Maria Turazza F; Mureddu G; Di Fusco SA; Lucà F; De Luca L; Camerini A; Halasz G; Camilli M; Quagliariello V; Maurea N; Fattirolli F; Gulizia MM; Gabrielli D; Grimaldi M; Colivicchi F; Oliva F Eur Heart J Suppl; 2024 Apr; 26(Suppl 2):ii252-ii263. PubMed ID: 38784673 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]